Back to Journals » Nature and Science of Sleep » Volume 17

Elevate Journal

Methodological Considerations Regarding the Article “Association Between Non-Benzodiazepine Hypnotics and Tinnitus: A Nationwide Cohort Study in Taiwan” [Letter]

Authors Wang Z ORCID logo, Shao L

Received 24 September 2025

Accepted for publication 25 September 2025

Published 29 September 2025 Volume 2025:17 Pages 2341—2342

DOI https://doi.org/10.2147/NSS.S569808

Checked for plagiarism Yes

Editor who approved publication: Dr Sarah L Appleton



Zhi Wang, Leping Shao

Department of Nephrology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People’s Republic of China

Correspondence: Leping Shao, Department of Nephrology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People’s Republic of China, Email [email protected]


View the original paper by Dr Lee and colleagues


Dear editor

We read with great interest the recent article by Kao et al in your journal, titled “Association Between Non-Benzodiazepine Hypnotics and Tinnitus: A Nationwide Cohort Study in Taiwan”.1 The study, which explores the association between Z-drugs and the risk of tinnitus, provides valuable data on this important public health issue. However, we would like to highlight several potential sources of bias that we noted were not addressed in the analysis.

First, the study design may have introduced immortal time bias. This bias typically arises when the exposure status of a subject is determined at some point after the start of follow-up.2 In this study, the bias originates from the definition of the exposed group (Z-drug users), where the index date was set as the date of the first Z-drug prescription. By this definition, any patient classified into this group must have survived free of tinnitus until that time point. This period of follow-up, from study entry to the first exposure, constitutes “immortal time” because it is a period during which the outcome is guaranteed not to occur by design. Misclassifying this risk-free immortal time into the follow-up of the exposed group introduces a potential systemic bias into the risk estimation, which can affect the accuracy of the Hazard Ratio (HR) estimate and complicate the interpretation of the association’s strength. To avoid this type of bias, established analytical strategies are available in epidemiological research, such as modeling the exposure as a time-varying covariate or performing a landmark analysis.2

Second, in the prospective analysis of risk, the authors employed a Cox Proportional Hazards (CoxPH) model.3 The validity of this model relies on its core proportional hazards (PH) assumption, which posits that the effect of a covariate remains constant over time. If this assumption is violated, the model may not provide unbiased coefficient estimates, and the results could be unreliable. Therefore, we recommend assessing the PH assumption for covariates associated with risk using methods such as Schoenfeld residuals.4 When the PH assumption does not hold, alternative models such as a stratified Cox model, a Cox model with time-dependent effects, or an Accelerated Failure Time (AFT) model would be more appropriate than the standard CoxPH model. Verifying and discussing this key assumption would greatly enhance readers’ confidence in the robustness of the study’s findings.5,6

We believe that clarification of these nuances will help readers of the journal to interpret the study’s findings more accurately.

Data Sharing Statement

Data sharing is not applicable to this communication as no data were created or analysed in this communication.

Author Contributions

Zhi Wang: Conceptualization, Project administration, Writing - Original Draft;

Leping Shao: Resources, Methodology, Writing - Review & Editing;

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; gave final approval of the version to be published; have agreed on the journal to which the communication has been submitted; and agree to be accountable for all aspects of the work.

Funding

There is no funding to report.

Disclosure

The authors declare no conflict of interest.

References

1. Lee JT, Yang HW, Yu CP, et al. Association between non-benzodiazepine hypnotics and tinnitus: a nationwide cohort study in Taiwan. Nat Sci Sleep. 2025;17:2213–2222. doi:10.2147/NSS.S545323

2. Larson DR, Crowson CS, Devick KL, Lewallen DG, Berry DJ, Maradit Kremers H. Immortal time bias in the analysis of time-to-event data in orthopedics. J Arthroplasty. 2021;36(10):3372–3377. doi:10.1016/j.arth.2021.06.012

3. Sheng A, Ghosh SK. Effects of proportional hazard assumption on variable selection methods for censored data. Stat Biopharm Res. 2020;12(2):199–209. doi:10.1080/19466315.2019.1694578

4. Xue X, Xie X, Gunter M, et al. Testing the proportional hazards assumption in case-cohort analysis. BMC Med Res Method. 2013;13:88. doi:10.1186/1471-2288-13-88

5. Blythe R, Parsons R, Barnett AG, Cook D, McPhail SM, White NM. Prioritising deteriorating patients using time-to-event analysis: prediction model development and internal-external validation. Crit Care. 2024;28(1):247. doi:10.1186/s13054-024-05021-y

6. Lee KH, Rondeau V, Haneuse S. Accelerated failure time models for semi-competing risks data in the presence of complex censoring. Biometrics. 2017;73(4):1401–1412. doi:10.1111/biom.12696

Creative Commons License © 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms and incorporate the Creative Commons Attribution - Non Commercial (unported, 4.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.